drugset / Trial / NCT04997941
Higher Dose Preoperative taMOxifen in Premenopausal bREast Cancer Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
MORE-T trial is designed to investigate the effect of Tamoxifen 40mg (vs. Tamoxifen 20mg) for 2wks in presurgical setting. The greater reduction in Ki-67 might be observed in Tamoxifen 40mg arm compared to the Tamoxifen 20mg arm. Open Label, Phase 2, Randomized with 1:1 allocation
Timeline
- Start
- 2021-10-21
- Primary completion
- 2024-12-31
- Completion
- 2028-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tamoxifen | Small molecule | 20 mg | Oral |
| Subject | Tamoxifen | Small molecule | 40 mg | Oral |